BioSpace News Archive

Press Releases

EISAI PRESENTS LATEST CLINICAL FINDINGS SUGGESTING INHIBITION OF TAU PROPAGATION BY ANTI-MTBR TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE CONFERENCE (CTAD)

October 31, 2024
·
4 min read
Press Releases

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

October 31, 2024
·
26 min read
Press Releases

Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura

October 31, 2024
·
5 min read
Press Releases

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

October 31, 2024
·
6 min read
Press Releases

Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

October 31, 2024
·
8 min read
Press Releases

Vistin Pharma ASA: Third quarter and YTD 2024 financial results

October 31, 2024
·
1 min read
Press Releases

Curevo Presents Positive Shingles Vaccine Outcomes Data

October 31, 2024
·
6 min read
Press Releases

Bausch Health Announces Third Quarter 2024 Results

October 31, 2024
·
44 min read
Press Releases

Tandem Diabetes Care Announces Upcoming Conference Participation

October 31, 2024
·
1 min read
Press Releases

ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024

October 31, 2024
·
4 min read